Controlled Environment Agriculture Research

Tiamat Sciences Achieves Breakthrough in mRNA Enzyme Production

Tiamat Sciences has successfully expressed T7 polymerase in its plant system, a significant step for mRNA vaccine synthesis. Agriculture News, AgTech news, AgTech, Agriculture.
Plant Molecular Farming Specialist cultivating Nicotiana benthamiana plants.

Key Takeaways

  1. A milestone in mRNA Enzyme Production: Tiamat Sciences has successfully expressed T7 polymerase in its plant system, a significant step for mRNA vaccine synthesis.
  2. Role of T7 Polymerase: This enzyme is crucial for synthesizing mRNA, essential for mRNA vaccines that trigger immune responses by instructing cells to produce antigen proteins.
  3. Implications for Vaccine Development: This achievement offers scalability, flexibility, and cost-effectiveness, enhancing pandemic preparedness and rapid vaccine production.
  4. Recent Advancements: Tiamat Sciences has also expressed human Fibroblast Growth Factor 2 (hFGF2) in plants, meeting demands in Regenerative Medicine.
  5. Strategic Partnerships: The company seeks co-development partnerships to advance plant-based reagent technology, emphasizing sustainability and global health.

Tiamat Sciences Corporation, a leading plant-based reagent company, has announced a significant milestone in mRNA enzyme production. The company has successfully expressed T7 polymerase, a critical enzyme for mRNA vaccine synthesis, within its plant system and aims to use it in mRNA production processes. This development represents a major step toward more efficient, sustainable, and scalable vaccine development methods.

The production of T7 polymerase is essential for mRNA vaccine production due to its role in synthesizing messenger RNA (mRNA). mRNA vaccines deliver mRNA molecules that encode specific antigens into the body. Once inside cells, these mRNA molecules instruct the cells to produce antigen proteins, triggering an immune response that leads to immunity against the targeted pathogen.

Tiamat Sciences: Harnessing Plant-Based Systems for Reagent Production

Tiamat Sciences’ achievement demonstrates the potential of plant-based systems to produce essential reagents. This innovation holds significant implications for the pharmaceutical industry, particularly in pandemic preparedness and rapid vaccine development. Producing critical enzymes like T7 polymerase in plant systems offers unparalleled flexibility, scalability, and cost-effectiveness, facilitating the accelerated production of mRNA vaccines on a global scale.

“We are thrilled to announce this milestone achievement demonstrating the diversity of reagents that we can make,” said France-Emmanuelle Adil, Co-Founder and CEO of Tiamat Sciences. “By successfully expressing T7 polymerase in plants, we have achieved a significant milestone that underscores the power of plant-based biotechnology to drive innovation and address critical challenges in healthcare.”

Advancements in Regenerative Medicine

In addition to the T7 polymerase achievement, Tiamat Sciences has successfully expressed human Fibroblast Growth Factor 2 (hFGF2) at a yield exceeding 20mg/kg biomass. This breakthrough enables further optimization to achieve even higher yields, meeting the demands of the Regenerative Medicine sector for affordable Cell & Gene therapies.

Supporting Innovation in Healthcare

While Tiamat Sciences does not manufacture vaccines, its reagents are vital in driving innovation in the healthcare and pharmaceutical sectors. Tiamat Sciences enables pharmaceutical companies to accelerate the development and production of life-saving treatments by providing essential tools and technologies.

Seeking Strategic Partnerships

Tiamat Sciences is actively seeking strategic co-development partnerships to advance this technology further and expedite the commercialization of plant-based reagents for vaccine production. With a commitment to sustainability, innovation, and global health, Tiamat Sciences aims to revolutionize the production of essential biomolecules, ensuring equitable access to life-saving treatments for people worldwide.

Image provided by Tiamat Sciences

administrator
As a dedicated journalist and entrepreneur, I helm iGrow News, a pioneering media platform focused on the evolving landscape of Agriculture Technology. With a deep-seated passion for uncovering the latest developments and trends within the agtech sector, my mission is to deliver insightful, unbiased news and analysis. Through iGrow News, I aim to empower industry professionals, enthusiasts, and the broader public with knowledge and understanding of technological advancements that shape modern agriculture. You can follow me on LinkedIn & Twitter.

Leave a Reply